Navigation Links
Injury Lawyers Release New Informational Graphic about the Alleged Link Between Victoza and Cancer
Date:9/6/2013

(PRWEB) September 06, 2013

Victoza (liraglutide) is a once-daily injection used to control blood sugar levels in type-2 diabetes patients. This medicine increases insulin while making the stomach feel full. The FDA approved this drug in January 2010 and it earned more than $2.3 billion in sales its first year on the market (i). Victoza, like all medicines, may cause side effects. According to the product’s website, the most common Victoza side effects were headache, nausea, and diarrhea. The manufacturer also warns that this drug may cause low blood sugar, pancreatitis, and cancer (ii). People who have suffered pancreatic cancer or thyroid cancer should talk to a personal injury attorney about their legal options.

As early as 2009 the FDA was concerned about the association between Victoza and cancer. The Agency reviewed the safety of the medicine in April 2009 and discovered twenty-nine cases of growths and tumors, including five cases of prostate cancer and five cases of thyroid cancer (iii). In June 2011, the FDA released new safety information on the drug highlighting the risk of thyroid cancer and acute pancreatitis with Victoza. The Agency also noted that this medicine is not recommended as the first choice for type-2 diabetes patients (iv). The most recent warning came in March 2013 when the FDA warned that the clinical trials had linked the drug to an “increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia.” Read the Drug Safety Communication here.

The Victoza infographic provides important information to type-2 diabetes patients, who are using the drug. Patients who have suffered Victoza side effects like cancer may be able to recover damages for medical bills, lost income, pain and suffering, and other injuries. d’Oliveira & Associates has been investigating these cases and the law firm is ready to answer any questions. They also work with some of the more experienced Victoza lawyers, who are handling these cases, and there are no legal fees unless you receive a settlement or award. Contact the law firm online or call 1-800-992-6878 for a free legal consultation.

(i) Novo Nordisk 2012 Annual Report.
webmedia.novonordisk.com/nncom/images/annual_report/2012/Novo-Nordisk-AR-2012-en.pdf
(ii) Product Website: Understanding Side Effects.
victoza.com/learn/usage-guidelines.aspx
(iii) Endocrine and Metabolic Drug Advisory Committee, April 2009.
fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148659.pdf%20FDA%20April%202009
(iv) Drug Safety Communication, March 2013.
fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258826.htm

Read the full story at http://www.prweb.com/releases/2013/9/prweb11070331.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Why is traumatic brain injury increasing among the elderly?
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Experts Offer Advice After Yankee Pitchers Trampoline Injury
5. Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia
6. Mild traumatic brain injury may contribute to brain network dysfunction
7. Injury-Linked Deaths Vary Widely Among States
8. Most occupational injury and illness costs are paid by the government and private payers
9. Diabetes drug could be a promising therapy for traumatic brain injury
10. Brain-Injury Recovery Varies Widely Among Children
11. Traumatic brain injury the focus of American Headache Society scientific conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/16/2017)... MO (PRWEB) , ... January 16, 2017 , ... St. Louisans are well-aware of the ... , This year’s influenza shot seems to be having no effect on keeping ... at least half of the people around are coughing, sneezing, or sniffling ...
(Date:1/16/2017)... ... 16, 2017 , ... Board-certified oculoplastic surgeon Dr. Mehryar (Ray) ... journal of The American Society for Aesthetic Plastic Surgery, in which he details ... to correct drooping, retracted lower eyelids, which usually result from genetics, injury, thyroid ...
(Date:1/16/2017)... ... , ... One thing common to all types of cancer is that it’s ... The money spent screening for and treating cancer in the United States is estimated ... more than in any other country that has an advanced healthcare system, sometimes spending ...
(Date:1/16/2017)... ... January 16, 2017 , ... ... Chief Executive Officer of the medical device company, effective immediately. , “This is ... “Kevin has a strong track record in medical device market development and ...
(Date:1/15/2017)... ... January 15, 2017 , ... In this role, Courtney will be responsible ... the asthma & allergy friendly mark. This certification program was created by ASL and ... products to be more suitable for the 60+ million people living in the U.S. ...
Breaking Medicine News(10 mins):
(Date:1/16/2017)... India , January 16, 2017 ... Market Research, titled, "Sterilization Technologies Market by Type and ... the global sterilization technologies market is expected to reach ... growing at a CAGR of 5.8% from 2016 to ... market in 2015, with more than half share, in ...
(Date:1/16/2017)...   Linde Gas North America LLC  today announced ... business of The Service Center LLC, a market leading provider ... providers in the Midwest and Southeast regions of the U.S. ... , The Service Center also has facilities in ... . Its primary services include: ...
(Date:1/16/2017)... FRANCISCO, Calif. , Jan. 16, 2017  Rigel ... on January 3, 2017 and January 16, 2017 the ... grant of inducement stock options to purchase an aggregate ... employees. These awards were granted pursuant to the Rigel ... material to the new employees entering into employment with ...
Breaking Medicine Technology: